{"DataElement":{"publicId":"2688031","version":"2","preferredName":"Hospital Specific Biological Response Modifier Type Number Code","preferredDefinition":"Records whether immunotherapeutic agents (biologic response modifiers) were administered as first-course treatment at this facility or the reason they were not given.","longName":"2688029v1.0:2645265v1.1","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"2688029","version":"1","preferredName":"Hospital Specific Biological Response Modifier","preferredDefinition":"Records whether immunotherapeutic agents (biologic response modifiers) were administered as first-course treatment at this facility or the reason they were not given.","longName":"2685312v1.0:2688027v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2685312","version":"1","preferredName":"Hospital Specified","preferredDefinition":"An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured.:Specified; clearly and explicitly stated.","longName":"C16696:C38024","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hospital","conceptCode":"C16696","definition":"An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specified","conceptCode":"C38024","definition":"Clearly and explicitly stated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAB4EA9-A05D-1E28-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2704291","version":"1","preferredName":"Biological Response Modifier","preferredDefinition":"Substances or procedures that enhance the host's ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host.","longName":"C308","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapeutic Agent","conceptCode":"C308","definition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4016C158-40E0-47F5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-11-29","modifiedBy":"ONEDATA","dateModified":"2007-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BFC93B0-8323-2263-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2645265","version":"1.1","preferredName":"Biological Response Modifier Type Number Code","preferredDefinition":"Substances or procedures that enhance the host's ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host._Type; a subdivision of a particular kind of thing._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification._A system of numbered categories for representation of data.","longName":"2645265v1.0","context":"PS-CC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"99","valueDescription":"It is unknown if immunotherapy was recommended or administered; death certificate-only cases.","ValueMeaning":{"publicId":"2645266","version":"1","preferredName":"It is unknown if immunotherapy was recommended or administered; death certificate-only cases.","longName":"2645266","preferredDefinition":"It is unknown if immunotherapy was recommended or administered; death certificate-only cases.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31B567BF-5015-2C18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE6B895A-D54B-A726-E040-BB89AD43702A","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"88","valueDescription":"Immunotherapy was recommended, but it is unknown if it was administered.","ValueMeaning":{"publicId":"2645267","version":"1","preferredName":"Immunotherapy was recommended, but it is unknown if it was administered.","longName":"2645267","preferredDefinition":"Immunotherapy was recommended, but it is unknown if it was administered.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31B567BF-503B-2C18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE6B895A-D555-A726-E040-BB89AD43702A","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"87","valueDescription":"Immunotherapy was not administered; it was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.","ValueMeaning":{"publicId":"2645268","version":"1","preferredName":"Immunotherapy was not administered; it was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.","longName":"2645268","preferredDefinition":"Immunotherapy was not administered; it was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31B567BF-5061-2C18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE6B895A-D55F-A726-E040-BB89AD43702A","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"86","valueDescription":"Immunotherapy was not administered; it was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was noted in the patient record.","ValueMeaning":{"publicId":"2645269","version":"1","preferredName":"Immunotherapy was not administered; it was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was noted in the patient record.","longName":"2645269","preferredDefinition":"Immunotherapy was not administered; it was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was noted in the patient record.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31B567BF-5087-2C18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE6B895A-D569-A726-E040-BB89AD43702A","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"85","valueDescription":"Immunotherapy was not administered because the patient died prior to planned or recommended therapy.","ValueMeaning":{"publicId":"2645270","version":"1","preferredName":"Immunotherapy was not administered because the patient died prior to planned or recommended therapy.","longName":"2645270","preferredDefinition":"Immunotherapy was not administered because the patient died prior to planned or recommended therapy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31B567BF-50AD-2C18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE6B895A-D573-A726-E040-BB89AD43702A","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"01","valueDescription":"Immunotherapy administered as first course therapy.","ValueMeaning":{"publicId":"2652786","version":"1","preferredName":"Immunotherapy administered as first course therapy.","longName":"2652786","preferredDefinition":"Immunotherapy administered as first course therapy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32B6955E-0ED8-0304-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE6B895A-D790-A726-E040-BB89AD43702A","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"00","valueDescription":"None, immunotherapy was not part of the first course of therapy; not customary therapy for this cancer.","ValueMeaning":{"publicId":"2645272","version":"1","preferredName":"None, immunotherapy was not part of the first course of therapy; not customary therapy for this cancer.","longName":"2645272","preferredDefinition":"None, immunotherapy was not part of the first course of therapy; not customary therapy for this cancer.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31B567BF-510F-2C18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE6B895A-D591-A726-E040-BB89AD43702A","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"82","valueDescription":"Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors (comorbid conditions, advanced age, etc.) or there was progression of disease prior to administration.","ValueMeaning":{"publicId":"3288190","version":"1","preferredName":"Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors (comorbid conditions, advanced age, etc.) or there was progression of disease prior to administration.","longName":"3288190","preferredDefinition":"Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors (comorbid conditions, advanced age, etc.) or there was progression of disease prior to administration.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6B895A-D5B6-A726-E040-BB89AD43702A","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE6B895A-D5CF-A726-E040-BB89AD43702A","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435016","version":"1","preferredName":"Chemotherapy Regimen","preferredDefinition":"Drug therapy using two or more drugs given together or separately for a combined effect.","longName":"C12218","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B9F7-9264-25C9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2661642","version":"1","preferredName":"Biological Response Modifier Type Number Code","preferredDefinition":"Substances or procedures that enhance the host's ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host.:Type; a subdivision of a particular kind of thing.:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.:A system of numbered categories for representation of data.","longName":"C308:C25284:C25337:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapeutic Agent","conceptCode":"C308","definition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"344B4B47-1C89-72B6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-02","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-07-02","modifiedBy":"ONEDATA","dateModified":"2007-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6B895A-D534-A726-E040-BB89AD43702A","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"CURTIST","dateModified":"2011-11-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"5899839","version":"1","longName":"HospitalSpecific16","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"7464313","version":"1","longName":"HospitalSpecific18","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"}]}],"AlternateNames":[{"name":"RX HOSP--BRM","type":"NAACCR Item Name","context":"PS-CC"},{"name":"720","type":"NAACCR Item #","context":"PS-CC"},{"name":"Immunotherapy at this Facility (CoC)","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"RX Hosp--BRM","type":"NAACCR Item Name","context":"PS-CC"}],"ReferenceDocuments":[{"name":"Note","type":"NOTE","description":"For tumors diagnosed on or after January 1, 2003, information on bone marrow transplants and stem cell transplants should be coded in the new field RX SUMM--Transplant/Endocr [3250]. Codes 02-06 should not be used for tumors diagnosed on or after Janaury 1, 2003.","url":null,"context":"PS-CC"},{"name":"COC-ROADS Manual","type":"REFERENCE","description":"Commission of Cancer Registry Operations and Data Standards Manual","url":"http://www.facs.org/cancer/coc/roads/roads1996.pdf","context":"PS-CC"},{"name":"RX Hospital Biological Respon","type":"Preferred Question Text","description":"RX Hospital Biological Response Modifier","url":null,"context":"PS-CC"},{"name":"RX Hosp--BRM Description","type":"COMMENT","description":"Immunotherapy consists of biological or chemical agents that alter the immune system or change the host's response to tumor cells.","url":null,"context":"PS-CC"},{"name":"FORDS Manual, Revised 2009","type":"REFERENCE","description":"See FORDS Manual for specifications of codes and data entry rules.","url":"http://www.facs.org/cancer/coc/fords/2009/fords2009.pdf","context":"PS-CC"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"PDF","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6B895A-D62F-A726-E040-BB89AD43702A","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-10-03","modifiedBy":"DWARZEL","dateModified":"2022-05-23","changeDescription":"10/03/2011 - tc - Updated VMs as per V12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}